| 000 | 01804 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516032143.0 | ||
| 264 | 0 | _c20111031 | |
| 008 | 201110s 0 0 eng d | ||
| 022 | _a1029-2403 | ||
| 024 | 7 |
_a10.3109/10428194.2011.566951 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHeutte, Natacha | |
| 245 | 0 | 0 |
_aQuality of life in 269 patients with poor-risk diffuse large B-cell lymphoma treated with rituximab versus observation after autologous stem cell transplant. _h[electronic resource] |
| 260 |
_bLeukemia & lymphoma _cJul 2011 |
||
| 300 |
_a1239-48 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aModels, Statistical |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aHaioun, Corinne | |
| 700 | 1 | _aFeugier, Pierre | |
| 700 | 1 | _aCoiffier, Bertrand | |
| 700 | 1 | _aTilly, Herve | |
| 700 | 1 | _aFerme, Christophe | |
| 700 | 1 | _aGabarre, Jean | |
| 700 | 1 | _aMorschhauser, Franck | |
| 700 | 1 | _aGisselbrecht, Christian | |
| 700 | 1 | _aMounier, Nicolas | |
| 773 | 0 |
_tLeukemia & lymphoma _gvol. 52 _gno. 7 _gp. 1239-48 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/10428194.2011.566951 _zAvailable from publisher's website |
| 999 |
_c20731252 _d20731252 |
||